Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Katsiaryna Bykov, Pharm.D., Sc.D.

Concepts (249)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Katsiaryna Bykov's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Katsiaryna Bykov has written about over time.
Ticlopidine, 3 publications between 2015 and 2017, average publication date October 2016. Drug Interactions, 11 publications between 2013 and 2021, average publication date June 2018. Cross-Over Studies, 4 publications between 2019 and 2020, average publication date August 2019. Warfarin, 6 publications between 2015 and 2023, average publication date October 2019. Analgesics, Opioid, 10 publications between 2016 and 2024, average publication date June 2021. Oxycodone, 2 publications between 2022 and 2022, average publication date April 2022. Venous Thromboembolism, 3 publications between 2022 and 2023, average publication date August 2022. Liver Function Tests, 1 publications between 2024 and 2024, average publication date June 2024. Phenylpropionates, 1 publications between 2024 and 2024, average publication date June 2024. Pyridazines, 1 publications between 2024 and 2024, average publication date June 2024. Tramadol, 2 publications between 2024 and 2024, average publication date August 2024.

To see the data from this visualization as text, click here.
Bykov's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (249)
Explore
_
Co-Authors (31)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.